Clinical Trials Update:&nbsp;Jan. 18, 2005
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
527274
roundup Plus: PMC-Sierra lowers forecast...WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations.
560209
In general, chemotherapy appears to increase the risk of stroke in patients with breast cancer. However, researchers report in the October 20th issue of the Journal of the National Cancer Institute.
539492
Neurocrine updates investors on the status of its top drugs.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
748131
China's SARS vaccine trials are expected to be completed by January as clinical experiments were going smoothly, state media reported.
730807
WASHINGTON - The Food and Drug Administration (news - web sites) will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
388739
Shares for Google slip for the first time since its public offering.  Also: FDA under fire for its slow Vioxx reaction & hellip;. Yahoo and SBC stay friends through new deal & hellip;. and more.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
627878
WEDNESDAY, Feb. 2 (HealthDayNews) -- The timing of systemic chemotherapy in patients with breast cancer does not affect patient survival or disease progression, say researchers reporting in the Feb. 2 issue of the Journal of the National Cancer Institute.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival